INCYTE CORP - Common Stock (INCY)

CUSIP: 45337C102

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / Common Stock
Shares outstanding
198,811,573
Total 13F shares
160,344,313
Share change
+350,330
Total reported value
$8,118,287,622
Put/Call ratio
104%
Price per share
$50.63
Number of holders
223
Value change
+$17,733,201
Number of buys
6
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 45337C102?
CUSIP 45337C102 identifies INCY - INCYTE CORP - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INCY - INCYTE CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
CITADEL ADVISORS LLC
13F
Company
1.1%
2,167,530
$82,691,000 30 Sep 2013
13F
PDT Partners, LLC
13F
Company
0.06%
118,828
$4,533,000 30 Sep 2013
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.05%
105,958
$4,042,000 30 Sep 2013
13F
Zurcher Kantonalbank (Zurich Cantonalbank)
13F
Company
0.02%
45,000
$1,717,000 30 Sep 2013
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
19,210
$733,000 30 Sep 2013
13F
AZZAD ASSET MANAGEMENT INC /ADV
13F
Company
0.01%
16,168
$616,809 30 Sep 2013
13F
HUNTINGTON NATIONAL BANK
13F
Company
0%
71
$3,000 30 Sep 2013
13F

Institutional Holders of INCYTE CORP - Common Stock (INCY) as of Q4 2013

As of 31 Dec 2013, INCYTE CORP - Common Stock (INCY) was held by 223 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 160,344,313 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Capital World Investors, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, Artisan Partners Limited Partnership, BB Biotech AG, ORBIMED ADVISORS LLC, BROWN CAPITAL MANAGEMENT LLC, and JENNISON ASSOCIATES LLC. This page lists 223 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2013 vs Q3 2013 Across Filers

Q3 2013 holders
7
Q4 2013 holders
223
Holder diff
216
Investor Q3 2013 Shares Q4 2013 Shares Share Diff Share Chg % Q3 2013 Value $ Q4 2013 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.